Arthritis drug Actemra in short supply as demand for use in COVID ramps up
By
Alicia Lasek
Aug 18, 2021
Demand for Actemra IV has skyrocketed due to the latest wave of COVID-19 infections and hospitalizations, drugmaker Genentech says. In the past two weeks alone, orders for the drug shot up to 400% of pre-COVID...
Pharmacies to long-term care: Get in front of COVID-19 vaccination questions
By
Alicia Lasek
Dec 07, 2020
With vaccine approval anticipated shortly, the best communicators will have the smoothest Phase 1 vaccination process, say Omnicare and PharMerica. Community pharmacies have recommendations as well.
Boosters on the way: LTC residents, healthcare workers may top fed’s list after CDC approves 3rd shot
By
Alicia Lasek
Aug 16, 2021
The Biden administration has secured 100 million COVID-19 vaccine doses as part of a strategy to provide additional shots to already vaccinated priority groups this fall, investigators have been told....
It’s official: Community pharmacies partner with feds for COVID vaccine distribution
By
Alicia Lasek
Nov 16, 2020
Future vaccines will be available to community pharmacies through partnerships with network
administrators, HHS has announced. The public-private collaboration will help cover expected distribution gaps,...
Moderna’s COVID vaccine tops 90% efficacy, can be refrigerated for 1 month
By
Alicia Lasek
Nov 17, 2020
Moderna’s trial vaccine will have big distribution advantages over Pfizer’s similarly successful candidate if both drugs are approved by the FDA.
Antigen tests may be less sensitive to omicron, FDA says
By
Alicia Lasek
Jan 04, 2022
Antigen tests may not be able to detect the omicron SARS-CoV-2 variant as well as they could previous variants, an early laboratory study has found.
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
Memory loss may linger eight months after mild coronavirus infection, study finds
By
Alicia Lasek
Aug 17, 2021
The results suggest that COVID-19 may not really be a mild disease, no matter its course, investigators say. They also raise the question of whether current home-treatment strategies are optimal for long-term...
COVID-19 a bigger threat to seniors than pneumonia, real-world study finds
By
Alicia Lasek
Feb 09, 2023
COVID-19 is much more deadly than bacterial or viral pneumonia, causing double the mortality rate in older, hospitalized adults, investigators say.
AMDA’s new COVID vaccine PowerPoint can help answer resident, staff concerns
By
Alicia Lasek
Dec 09, 2020
A toolkit created by industry clinicians aims to help long-term care operators address questions about getting vaccinated. A PowerPoint presentation is available to share with staff and residents.